Development of an innovative mammalian USP manufacturing platform for therapeutic biologics.

• Unité de recherche: INNOSUISSE
• Numéro de projet: 34741.1 IP-LS
• Titre du projet anglais: Development of an innovative mammalian USP manufacturing platform for therapeutic biologics.

Description succincte (Allemand)

Development of an innovative mammalian USP manufacturing platform for therapeutic biologics.

Description succincte (Anglais)

Development of an innovative mammalian USP manufacturing platform for therapeutic biologics.

Résumé des résultats (Abstract) (Allemand)

HES-SO Valais/Wallis and Ferring Pharmaceuticals are developing an innovative and cost-effective mammalian USP platform for therapeutic biologics. Proof-of-concept will be achieved by applying the development to the manufacturing of new therapeutic protein to be marketed.